Sideroblastic anemia medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Sideroblastic anemia}} | {{Sideroblastic anemia}} | ||
{{CMG}} | {{CMG}} | ||
== Medical Therapy == | == Medical Therapy == | ||
The anemia can be so severe that support with transfusion is required. These patients usually do not respond to [[erythropoietin]] therapy. | The anemia can be so severe that support with transfusion is required. These patients usually do not respond to [[erythropoietin]] therapy. Some cases have been reported that the anemia is reversed or heme level is improved through use of moderate to high doses of Pyrodoxine (Vitamin B6.) | ||
==References== | ==References== | ||
| Line 14: | Line 14: | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:needs overview]] | |||
Revision as of 17:01, 4 February 2013
|
Sideroblastic anemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sideroblastic anemia medical therapy On the Web |
|
American Roentgen Ray Society Images of Sideroblastic anemia medical therapy |
|
Risk calculators and risk factors for Sideroblastic anemia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
The anemia can be so severe that support with transfusion is required. These patients usually do not respond to erythropoietin therapy. Some cases have been reported that the anemia is reversed or heme level is improved through use of moderate to high doses of Pyrodoxine (Vitamin B6.)